Compare $BRTX vs $VIVS | Chartloom

Compare

$BRTX vs $VIVS

BioRestorative Therapies Inc · VivoSim Labs Inc

BRTX

BioRestorative Therapies Inc

VIVS

VivoSim Labs Inc

Compare $BRTX vs $VIVS

Comparing BioRestorative Therapies Inc and VivoSim Labs Inc

BRTXBioRestorative Therapies Inc

VIVSVivoSim Labs Inc

BRTXBioRestorative Therapies Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-8.5%

YTD performance

-92.2%

52W performance

-94.2%

FCF yield

-24.4%

VIVSVivoSim Labs Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-21.1%

YTD performance

-90.4%

52W performance

-94.3%

FCF yield

-466.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BRTX

VIVS

Detailed metrics comparison

BRTX

BioRestorative Therapies Inc

VIVS

VivoSim Labs Inc

Market Cap

BRTX$49M

VIVS$2M

Enterprise Value

BRTX$46M

VIVS$502K

Price

BRTX$1.91

VIVS$0.18

P/E Ratio

BRTXN/A

VIVSN/A

P/S Ratio

BRTX135.98x

VIVS19.39x

EV/Sales

BRTX127.28x

VIVS4.48x

EV/EBITDA

BRTX0.00x

VIVS0.00x

P/B Ratio

BRTX0.98x

VIVS0.73x

P/FCF Ratio

BRTXN/A

VIVSN/A

EV/FCF

BRTX-3.83x

VIVS-0.05x

PEG Ratio

BRTXN/A

VIVSN/A

Forward P/E (NTM)

BRTXN/A

VIVSN/A

Forward P/S (NTM)

BRTXN/A

VIVSN/A

Revenue (TTM)

BRTX$358K

VIVS$112K

Revenue Growth (YoY)

BRTX-8.5%

VIVS-21.1%

Forward Rev Growth

BRTX64.6%

VIVS0.0%

Gross Margin (TTM)

BRTX92.1%

VIVS83.9%

Operating Margin (TTM)

BRTX0.0%

VIVS0.0%

EBITDA Margin (TTM)

BRTX-3915.8%

VIVS-9943.8%

Net Margin (TTM)

BRTX-3089.3%

VIVS-11016.1%

FCF Margin (TTM)

BRTX-3324.3%

VIVS-9038.4%

Net Income (TTM)

BRTX$-11M

VIVS$-12M

FCF (TTM)

BRTX$-12M

VIVS$-10M

EPS (TTM)

BRTX-$12.47

VIVS-$2.35

ROE (TTM)

BRTX-42384.0%

VIVS-1556.0%

ROA (TTM)

BRTX-19330.0%

VIVS-17702.0%

ROIC (TTM)

BRTX-42384.0%

VIVS-1556.0%

Cash

BRTX$3M

VIVS$2M

Debt

BRTX$0

VIVS$0

Net Cash/Debt

BRTX$3M

VIVS$2M

Current Ratio (TTM)

BRTX2.35x

VIVS1.70x

Quick Ratio (TTM)

BRTX2.23x

VIVS1.43x

Debt/Equity (TTM)

BRTX0.00x

VIVS0.00x

Debt/Assets (TTM)

BRTX0.0%

VIVS0.0%

Interest Coverage (TTM)

BRTXN/A

VIVSN/A

Net Debt/EBITDA (TTM)

BRTX0.00x

VIVS0.00x

Beta

BRTX0.80

VIVS1.57

52W Performance

BRTX-94.2%

VIVS-94.3%

YTD Performance

BRTX-92.2%

VIVS-90.4%

% from 52W High

BRTX-94.5%

VIVS-94.9%

% from 52W Low

BRTX9.1%

VIVS7.2%

Asset Turnover (TTM)

BRTX0.06x

VIVS0.02x

FCF Yield (TTM)

BRTX-24.4%

VIVS-466.1%

Earnings Yield (TTM)

BRTX-22.7%

VIVS-568.0%

Dividend Yield (TTM)

BRTXN/A

VIVSN/A

Rule of 40

BRTX-3,332.8

VIVS-9,059.5

EV/GP/RG

BRTX2.12

VIVSN/A

Ticker research

View BRTX research View VIVS research

Metric	BRTX BioRestorative Therapies Inc	VIVS VivoSim Labs Inc
Market & Valuation
Market Cap	$49M	$2M
Enterprise Value	$46M	$502K
Price	$1.91	$0.18
P/E Ratio	N/A	N/A
P/S Ratio	135.98x	19.39x
EV/Sales	127.28x	4.48x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.98x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.83x	-0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$358K	$112K
Revenue Growth (YoY)	-8.5%	-21.1%
Forward Rev Growth	64.6%	0.0%
Profitability
Gross Margin (TTM)	92.1%	83.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3915.8%	-9943.8%
Net Margin (TTM)	-3089.3%	-11016.1%
FCF Margin (TTM)	-3324.3%	-9038.4%
Net Income (TTM)	$-11M	$-12M
FCF (TTM)	$-12M	$-10M
EPS (TTM)	-$12.47	-$2.35
ROE (TTM)	-42384.0%	-1556.0%
ROA (TTM)	-19330.0%	-17702.0%
ROIC (TTM)	-42384.0%	-1556.0%
Financial Health
Cash	$3M	$2M
Debt	$0	$0
Net Cash/Debt	$3M	$2M
Current Ratio (TTM)	2.35x	1.70x
Quick Ratio (TTM)	2.23x	1.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	1.57
52W Performance	-94.2%	-94.3%
YTD Performance	-92.2%	-90.4%
% from 52W High	-94.5%	-94.9%
% from 52W Low	9.1%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-24.4%	-466.1%
Earnings Yield (TTM)	-22.7%	-568.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,332.8	-9,059.5
EV/GP/RG	2.12	N/A
Ticker research	View BRTX research	View VIVS research

Valuation

P/S Ratio

VIVS

19.39x

BRTX

135.98x

EV/FCF

BRTX

-3.83x

VIVS

-0.05x

Growth & revenue

Revenue Growth TTM

BRTX

-8.5%

VIVS

-21.1%

Forward Revenue Growth

BRTX

64.6%

VIVS

0.0%

Profitability & performance

Gross Margin

BRTX

92.1%

VIVS

83.9%

ROE

VIVS

-1556.0%

BRTX

-42384.0%

FCF Yield %

BRTX

-24.4%

VIVS

-466.1%

52-Week Performance

BRTX

-94.2%

VIVS

-94.3%

Detailed metrics comparison

BRTX

BioRestorative Therapies Inc

VIVS

VivoSim Labs Inc

Market Cap

BRTX$49M

VIVS$2M

Enterprise Value

BRTX$46M

VIVS$502K

Price

BRTX$1.91

VIVS$0.18

P/E Ratio

BRTXN/A

VIVSN/A

P/S Ratio

BRTX135.98x

VIVS19.39x

EV/Sales

BRTX127.28x

VIVS4.48x

EV/EBITDA

BRTX0.00x

VIVS0.00x

P/B Ratio

BRTX0.98x

VIVS0.73x

P/FCF Ratio

BRTXN/A

VIVSN/A

EV/FCF

BRTX-3.83x

VIVS-0.05x

PEG Ratio

BRTXN/A

VIVSN/A

Forward P/E (NTM)

BRTXN/A

VIVSN/A

Forward P/S (NTM)

BRTXN/A

VIVSN/A

Revenue (TTM)

BRTX$358K

VIVS$112K

Revenue Growth (YoY)

BRTX-8.5%

VIVS-21.1%

Forward Rev Growth

BRTX64.6%

VIVS0.0%

Gross Margin (TTM)

BRTX92.1%

VIVS83.9%

Operating Margin (TTM)

BRTX0.0%

VIVS0.0%

EBITDA Margin (TTM)

BRTX-3915.8%

VIVS-9943.8%

Net Margin (TTM)

BRTX-3089.3%

VIVS-11016.1%

FCF Margin (TTM)

BRTX-3324.3%

VIVS-9038.4%

Net Income (TTM)

BRTX$-11M

VIVS$-12M

FCF (TTM)

BRTX$-12M

VIVS$-10M

EPS (TTM)

BRTX-$12.47

VIVS-$2.35

ROE (TTM)

BRTX-42384.0%

VIVS-1556.0%

ROA (TTM)

BRTX-19330.0%

VIVS-17702.0%

ROIC (TTM)

BRTX-42384.0%

VIVS-1556.0%

Cash

BRTX$3M

VIVS$2M

Debt

BRTX$0

VIVS$0

Net Cash/Debt

BRTX$3M

VIVS$2M

Current Ratio (TTM)

BRTX2.35x

VIVS1.70x

Quick Ratio (TTM)

BRTX2.23x

VIVS1.43x

Debt/Equity (TTM)

BRTX0.00x

VIVS0.00x

Debt/Assets (TTM)

BRTX0.0%

VIVS0.0%

Interest Coverage (TTM)

BRTXN/A

VIVSN/A

Net Debt/EBITDA (TTM)

BRTX0.00x

VIVS0.00x

Beta

BRTX0.80

VIVS1.57

52W Performance

BRTX-94.2%

VIVS-94.3%

YTD Performance

BRTX-92.2%

VIVS-90.4%

% from 52W High

BRTX-94.5%

VIVS-94.9%

% from 52W Low

BRTX9.1%

VIVS7.2%

Asset Turnover (TTM)

BRTX0.06x

VIVS0.02x

FCF Yield (TTM)

BRTX-24.4%

VIVS-466.1%

Earnings Yield (TTM)

BRTX-22.7%

VIVS-568.0%

Dividend Yield (TTM)

BRTXN/A

VIVSN/A

Rule of 40

BRTX-3,332.8

VIVS-9,059.5

EV/GP/RG

BRTX2.12

VIVSN/A

Ticker research

View BRTX research View VIVS research

Metric	BRTX BioRestorative Therapies Inc	VIVS VivoSim Labs Inc
Market & Valuation
Market Cap	$49M	$2M
Enterprise Value	$46M	$502K
Price	$1.91	$0.18
P/E Ratio	N/A	N/A
P/S Ratio	135.98x	19.39x
EV/Sales	127.28x	4.48x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.98x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.83x	-0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$358K	$112K
Revenue Growth (YoY)	-8.5%	-21.1%
Forward Rev Growth	64.6%	0.0%
Profitability
Gross Margin (TTM)	92.1%	83.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3915.8%	-9943.8%
Net Margin (TTM)	-3089.3%	-11016.1%
FCF Margin (TTM)	-3324.3%	-9038.4%
Net Income (TTM)	$-11M	$-12M
FCF (TTM)	$-12M	$-10M
EPS (TTM)	-$12.47	-$2.35
ROE (TTM)	-42384.0%	-1556.0%
ROA (TTM)	-19330.0%	-17702.0%
ROIC (TTM)	-42384.0%	-1556.0%
Financial Health
Cash	$3M	$2M
Debt	$0	$0
Net Cash/Debt	$3M	$2M
Current Ratio (TTM)	2.35x	1.70x
Quick Ratio (TTM)	2.23x	1.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	1.57
52W Performance	-94.2%	-94.3%
YTD Performance	-92.2%	-90.4%
% from 52W High	-94.5%	-94.9%
% from 52W Low	9.1%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-24.4%	-466.1%
Earnings Yield (TTM)	-22.7%	-568.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,332.8	-9,059.5
EV/GP/RG	2.12	N/A
Ticker research	View BRTX research	View VIVS research